These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The increased susceptibility to hydrogen peroxide of the (post-)ischemic rat heart is associated with the magnitude of the low molecular weight iron pool. Voogd A, Sluiter W, Koster JF. Free Radic Biol Med; 1994 Apr; 16(4):453-8. PubMed ID: 8005530 [Abstract] [Full Text] [Related]
4. Effects of deferoxamine on H2O2-induced oxidative stress in isolated rat heart. Dulchavsky SA, Davidson SB, Cullen WJ, Devasagayam TP, Diebel LN, Dutta S. Basic Res Cardiol; 1996 Apr; 91(6):418-24. PubMed ID: 8996626 [Abstract] [Full Text] [Related]
5. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Williams RE, Zweier JL, Flaherty JT. Circulation; 1991 Mar; 83(3):1006-14. PubMed ID: 1847847 [Abstract] [Full Text] [Related]
7. Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Myers ML, Farhangkhoee P, Karmazyn M. Cardiovasc Res; 1998 Nov; 40(2):290-6. PubMed ID: 9893722 [Abstract] [Full Text] [Related]
8. Role of low molecular weight iron in functional preconditioning of the isolated rat heart. Asimakis GK, Inners KF, Ethridge RT. J Mol Cell Cardiol; 1997 Apr; 29(4):1087-96. PubMed ID: 9160861 [Abstract] [Full Text] [Related]
9. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation. Reznick AZ, Kagan VE, Ramsey R, Tsuchiya M, Khwaja S, Serbinova EA, Packer L. Arch Biochem Biophys; 1992 Aug 01; 296(2):394-401. PubMed ID: 1321584 [Abstract] [Full Text] [Related]
10. Effect of beta2-adrenergic agonist clenbuterol on ischemia/reperfusion injury in isolated rat hearts and cardiomyocyte apoptosis induced by hydrogen peroxide. Liu P, Xiang JZ, Zhao L, Yang L, Hu BR, Fu Q. Acta Pharmacol Sin; 2008 Jun 01; 29(6):661-9. PubMed ID: 18501112 [Abstract] [Full Text] [Related]
11. Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Protective effects of deferoxamine. Menasche P, Grousset C, Gauduel Y, Mouas C, Piwnica A. Circulation; 1987 Nov 01; 76(5 Pt 2):V180-5. PubMed ID: 2822288 [Abstract] [Full Text] [Related]
12. The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes. Horackova M, Ponka P, Byczko Z. Cardiovasc Res; 2000 Aug 18; 47(3):529-36. PubMed ID: 10963725 [Abstract] [Full Text] [Related]
18. Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine. van der Kraaij AM, Mostert LJ, van Eijk HG, Koster JF. Circulation; 1988 Aug 18; 78(2):442-9. PubMed ID: 3396180 [Abstract] [Full Text] [Related]
19. Age-dependent changes in myocardial susceptibility to zero flow ischemia and reperfusion in isolated perfused rat hearts: relation to antioxidant status. Boucher F, Tanguy S, Besse S, Tresallet N, Favier A, de Leiris J. Mech Ageing Dev; 1998 Jul 15; 103(3):301-16. PubMed ID: 9723905 [Abstract] [Full Text] [Related]